Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Good long-term results of sacral neuromodulation for endometriosis related chronic pelvic pain

Zegrea, Adrian; Ojala, Emilia; Kirss, Jaan; Suvitie, Pia; Varpe, Pirita; Makela-Kaikkonen, Johanna; Rautio, Tero; Seikkula, Jaana; Ukkonen, Mika; Lavonius, Maija; Pinta, Tarja

Good long-term results of sacral neuromodulation for endometriosis related chronic pelvic pain

Zegrea, Adrian
Ojala, Emilia
Kirss, Jaan
Suvitie, Pia
Varpe, Pirita
Makela-Kaikkonen, Johanna
Rautio, Tero
Seikkula, Jaana
Ukkonen, Mika
Lavonius, Maija
Pinta, Tarja
Katso/Avaa
s12905-025-03699-y.pdf (1.045Mb)
Lataukset: 

Springer Science and Business Media LLC
doi:10.1186/s12905-025-03699-y
URI
https://doi.org/10.1186/s12905-025-03699-y
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2025082791501
Tiivistelmä

Background: Sacral neuromodulation (SNM) is an established therapy in urology and gastroenterological surgery for treatment of overactive bladder symptoms, urge urinary incontinence or fecal incontinence. SNM has also been used with good results in patients with chronic pelvic pain (CPP). Our aim was to analyze long-term results of SNM in Finnish patients with endometriosis related CPP.

Methods: This is a register-based retrospective study including all the endometriosis patients treated with SNM for CPP in Finland between 2004 and 2017. There were four centers where these procedures were performed, two University Hospitals and two Central Hospitals. Long-term results were assessed by phone interview in spring 2021.

Results: A total of 16 women with endometriosis, with a median age of 39 (25-50) years, underwent SNM treatment for chronic pelvic pain (CPP), with the median follow-up time of 73 (48-85) months. The Implantable Pulse Generator (IPG) was implanted to 14 patients (88%). By the end of the follow-up period, 10 patients (62,5% of all patients and 71% of those who received IPG) had a functional SNM. Pain was assessed by numeral rating scale (NRS) and decreased from a median of 7.4 (3.6-10) to 2.3 (0-6.5).

Conclusions: SNM could be a good option in the treatment of endometriosis related chronic pelvic pain when standard therapy is not enough.

Kokoelmat
  • Rinnakkaistallenteet [27094]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste